My HPRA: Register

OCTREOTIDE

0.2 Mg/Ml Solution for Injection

Hospira UK LimitedPA0437/059/003

SPC: DATE OF REVISION OF THE TEXT

06 May 2016 - 04 Oct 2016	04 Oct 2016 - Present
April 2016	September 2016

« Back

Follow medicine

Print

Latest Changes to Medicine Info & SPC

04 Oct 2016
SPC: DATE OF REVISION OF THE TEXT
04 Oct 2016
SPC: MARKETING AUTHORISATION NUMBER
04 Oct 2016
SPC: Special precautions for disposal and other handling
04 Oct 2016
SPC: Shelf life
04 Oct 2016
SPC: Incompatibilities
04 Oct 2016
SPC: Preclinical safety data
04 Oct 2016
SPC: Pharmacokinetic properties
04 Oct 2016
SPC: Pharmacodynamic properties
04 Oct 2016
SPC: Overdose
04 Oct 2016
SPC: Undesirable effects
04 Oct 2016
SPC: Effects on ability to drive and use machines
04 Oct 2016
SPC: Fertility, pregnancy and lactation
04 Oct 2016
SPC: Interaction with other medicinal products and other forms of interaction
04 Oct 2016
SPC: Special warnings and precautions for use
04 Oct 2016
SPC: Contraindications
04 Oct 2016
SPC: Posology and method of administration
04 Oct 2016
SPC: Therapeutic Indications
04 Oct 2016
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
29 Sep 2016
SPC: MARKETING AUTHORISATION HOLDER
29 Sep 2016
SPC: Undesirable effects
06 May 2016
SPC: DATE OF REVISION OF THE TEXT
06 May 2016
SPC: QUALITATIVE AND QUANTITATIVE COMPOSITION
06 May 2016
SPC: NAME OF THE MEDICINAL PRODUCT

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.

Important information regarding cookies and the HPRA

By using this website, you consent to the use of cookies in accordance with the HPRA Cookie Policy.
For more information on cookies, see our cookie policy.

Click here to accept the cookie policy and hide this message